Announcement PDF ( 25 February 2025 Company Announcements Platform ASX Limited Dear Sir/Madam, Notices received under s203D and s249D of the Corporations Act 2001 (Cth) Percheron Therapeutics Limited ACN 095 060 745 (Company) wishes to advise that it has received purported notices under sections 203D(2) and 249D of the Corporations Act 2001 (Cth) (Corporations Act) on behalf of Powerhouse Ventures Limited ACN 612 076 169 (Requisitioning Shareholder) who holds over 5% of the votes that may be cast at a general meeting of the Company. The Requisitioning Shareholder has also provided the Company with a member’s statement under Section 249P of the Corporations Act. The purported notice under Section 203D of the Corporations Act was received by the Company on 21 February 2025 and gives notice of the Requisitioning Shareholder’s intention to move at a general meeting of the Company, resolutions to remove the directors of the Company (as detailed further below). The Board does not consider Resolutions 1, 2, 3, 6, 7 and 8 to be in the best interest of the Company and recommends you vote AGAINST these resolutions. The purported notice under section 249D of the Corporations Act was received by the Company on 24 February 2025 and requests the Company call and arrange to hold a general meeting of the Company (General Meeting). The business at the General Meeting is to consider, and if thought fit, pass the following separate resolutions as ordinary resolutions: Resolution1 – Removal of Dr Charmaine Gittleson as a Director “That, pursuant to section 203D(1) of the Corporations Act 2001 (Cth), Dr Charmaine Gittleson be removed as a director of the Company effective immediately on the passing of this resolution.” Resolution 2 – Removal of Dr James Garner as a Director “That, pursuant to section 203D(1) of the Corporations Act 2001 (Cth), Dr James Garner be removed as a director of the Company effective immediately on the passing of this resolution.” Resolution 3 – Removal of Dr Ben Gil Price as a Director “That, pursuant to section 203D(1) of the Corporations Act 2001 (Cth), Dr Ben Gil Price be removed as a director of the Company effective immediately on the passing of this resolution.” L30, Collins Place, 35 Collins Street, Melbourne, VIC 3000, Australia E: in fo@Perch eron Tx . co m ■ T : +61 3 9827 8999 ME_225494579_1 www.Per ch er o nT x. c om Resolution 4 – Removal of Mr Greg Peters as a Director (if appointed as a Director before the meeting) “That, pursuant to section 203D(1) of the Corporations Act 2001 (Cth), Mr Gregory Peters (if appointed as a director before the meeting) be removed as a director of the Company effective immediately on the passing of this resolution.” Resolution 5 – Removal of Mr Gennadi Koutchin as a Director (if appointed as a Director before the meeting) “That, pursuant to section 203D(1) of the Corporations Act 2001 (Cth), Mr Gennadi Koutchin (if appointed as a director before the meeting) be removed as a director of the Company effective immediately on the passing of this resolution.” Resolution 6 – Appointment of Doran Eldar as a Director “That Doron Eldar, having consented to act as a director of the Company, be appointed as a director of the Company effective immediately on the passing of this resolution.” Resolution 7 – Appointment of Julian Chick as a Director “That Julian Chick, having consented to act as a director of the Company, be appointed as a director of the Company effective immediately on the passing of this resolution.” Resolution 8 – Appointment of Richard Hamersley as a Director “That Richard Hamersley, having consented to act as a director of the Company, be appointed as a director of the Company effective immediately on the passing of this resolution.” If the purported notices are deemed to be valid the directors are required to call a general meeting within 21 days after receipt of a valid request pursuant to section 249D of the Corporations Act and the meeting is to be held no later than 2 months after the request is given to the company. The Company will consider the notices and will comply with its legal obligations in all respects. Shareholders are advised that the purported notices received on 21 February 2025 and 24 February 2025 are not related to the notices under s203D and s249D of the Corporations Act 2001 announced on 7 January 2025. The general meeting for these notices will be held on 4 March 2025 and the Board encourages shareholders to vote AGAINST ALL resolutions at that meeting. Yours sincerely Deborah Ambrosini Company Secretary Percheron Therapeutics Limited Page 2 of 2